People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tamir Biotechnology, Inc. | — | Biotechnology | Seed | $8.4M | $35.9M | 2014 |
Patrick Ostronick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Ostronick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Sidransky | 1 | 7 |
| Paul Weiss | 1 | 5 |
| John Brancaccio | 1 | 5 |
| Paul M. Weiss | 1 | 4 |
| Patrick Ostronic | 1 | 3 |
| John P. Brancaccio | 1 | 3 |
| Lawrence A. Kenyon | 1 | 2 |
| Stephen K. Carter | 1 | 2 |
| David Sidrandky | 1 | 1 |
| Joanne Barsa | 1 | 1 |
| Fred Knoll | 1 | 1 |
| Kuslima M. Shogen | 1 | 1 |
| Jamie Sully | 1 | 1 |
| Jamie Sulley | 1 | 1 |
| Charles M. Muniz | 1 | 1 |
| Donald R. Conklin | 1 | 1 |
| Charles Muniz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.